CLINICAL_TRIALS ClinicalTrials.gov record update

A Multi-centre Phase II Trial of GVHD Prophylaxis Following Unrelated Donor Stem Cell Transplantation Comparing Thymoglobulin vs. Calcineurin Inhibitor or Sirolimus-based Post-transplant Cyclophosphamide

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04888741
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:33.833873+00:00
Published At: 2023-09-28T00:00:00+00:00
Record Updated At: 2023-09-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndromes", "Non Hodgkin Lymphoma", "Hodgkin Lymphoma", "Multiple Myeloma", "Chronic Myelogenous Leukemia", "Myelofibrosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-09-28"
protocolSection.identificationModule.nctId: "NCT04888741"
protocolSection.identificationModule.officialTitle: "A Multi-centre Phase II Trial of GVHD Prophylaxis Following Unrelated Donor Stem Cell Transplantation Comparing Thymoglobulin vs. Calcineurin Inhibitor or Sirolimus-based Post-transplant Cyclophosphamide"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.